Using 3'-azido-2',3'-dideoxythymidine (AZT) to prevent perinatal human immunodeficiency virus transmission and risk of transplacental carcinogenesis. [electronic resource]
Producer: 19971125Description: 1566-7 p. digitalISSN:- 0027-8874
- Animals
- Anti-HIV Agents -- administration & dosage
- Carcinogens -- administration & dosage
- Female
- HIV Infections -- prevention & control
- Humans
- Infant, Newborn
- Infectious Disease Transmission, Vertical -- prevention & control
- Mice
- National Institutes of Health (U.S.)
- Placenta
- Pregnancy
- Pregnancy Complications, Infectious
- Risk
- United States
- Zidovudine -- administration & dosage
No physical items for this record
Publication Type: Comment; Editorial
There are no comments on this title.
Log in to your account to post a comment.